MUTTA
Summary of public USPTO data
- Owner
- Aarvik Therapeutics, Inc.
- Status
- Live/Registered
- Serial number
- 97435951
- Registration number
- 8513622
- Filing date
- 2022-05-31
- Registration date
- 2026-10-20
- International classes
- 1, 5, 42, 44
Goods and services
Class 1
- Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific therapeutic antibodies for scientific and medical research
Class 5
- Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific reagent antibodies for medical diagnosis purposes
Class 42
- Providing prescription drug research information relating to cancer drugs
Class 44
- Providing healthcare information regarding cancer drugs and cancer treatment